Pasteur Gene Targeting Patents Are Valid, Fed. Circ. Told

Law360, Washington (October 7, 2013, 5:26 PM EDT) -- French nonprofit research organization the Pasteur Institute asked the Federal Circuit on Monday to toss a U.S. Patent and Trademark Office ruling that gutted three of its gene targeting patents, saying the office erred in finding the patents invalid due to obviousness.

Pasteur Institute counsel Thomas H. Jenkins told a three-judge panel that the USPTO erred in nixing claims in three patents due to obviousness at a patent re-examination requested by Precision Biosciences Inc. The patents address the insertion or deletion of genes at specific locations...
To view the full article, register now.